Asaf Danon

Asaf Danon

Auto-generated profile, based on publicly available information

Asaf Danon

Department of Cardiology Lady Davis Carmel Medical Center Haifa Israel

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
SMSimcha R. Meisel
Simcha R. Meisel
MKMichael Kleiner‐Shochat
Michael Kleiner‐Shochat
RARami Abu‐Fanne
Rami Abu‐Fanne
AFAaron Frimerman
Aaron Frimerman
ADAsaf Danon
Asaf Danon
ARAriel Roguin
Ariel Roguin
Background: Shortening the pain‐to‐balloon (P2B) and door‐to‐balloon (D2B) intervals in patients with ST‐segment–elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention (PPCI) is essential in order to limit myocardial damage. We investigated whether direct admission of PPCI‐treated patients with STEMI to the catheterization laboratory, bypassing the emergency department, expedites reperfusion and improves prognosis. Methods and Results: Consecutive PPCI‐treated patients with STEMI included in the ACSIS (Acute Coronary Syndrome in Israel Survey), a prospective nationwide multicenter registry, were divided into patients admitted directly or via the emergency department. The impact of the P2B and D2B intervals on mortality was compared between groups by logistic regression and propensity score matching. Of the 4839 PPCI‐treated patients with STEMI, 1174 were admitted directly and 3665 via the emergency department. Respective median P2B and D2B were shorter among the directly admitted patients with STEMI (160 and 35 minutes) compared with those admitted via the emergency department (210 and 75 minutes, P <0.001). Decreased mortality was observed with direct admission at 1 and 2 years and at the end of follow‐up (median 6.4 years, P <0.001). Survival advantage persisted after adjustment by logistic regression and propensity matching. P2B, but not D2B, impacted survival ( P <0.001). Conclusions: Direct admission of PPCI‐treated patients with STEMI decreased mortality by shortening P2B and D2B intervals considerably. However, P2B, but not D2B, impacted mortality. It seems that the D2B interval has reached its limit of effect. Thus, all efforts should be extended to shorten P2B by educating the public to activate early the emergency medical services to bypass the emergency department and allow timely PPCI for the best outcome.

1 October 2013 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
MSMohammed Shurrab
Mohammed Shurrab
CMCarlos A. Morillo
Carlos A. Morillo
SSSam Schulman
Sam Schulman
NKNitin Kansal
Nitin Kansal
ADAsaf Danon
Asaf Danon
ECEugene Crystal
Eugene Crystal

1 August 2019 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
ADAsaf Danon
Asaf Danon
AMArie Militianu
Arie Militianu
JSJorge E. Schliamser
Jorge E. Schliamser

1 November 2017 in Journal of Electrocardiology
Verified
Journal Article
Closed access
ADAsaf Danon
Asaf Danon
MSMohammed Shurrab
Mohammed Shurrab

15 January 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
OROrna Reges
Orna Reges
WAWiessam Abu Ahmad
Wiessam Abu Ahmad
EBErez Battat
Erez Battat
WSWalid Saliba
Walid Saliba
YSYael Wolff Sagy
Yael Wolff Sagy
GLGil Lavie
Gil Lavie
Prior studies found reduced incidences of cardiovascular diagnoses and treatments in the initial phase of the COVID-19 pandemic. However, these studies included a limited number of outcomes and did not consider pre-pandemic trends. This study aimed to describe trends in the incidence of cardiovascular diagnoses and treatments over the years 2012–2021 in Israel and to compare the two years of the COVID-19 period with the preceding 8 years. In this retrospective, population-based study, carried out within Clalit Health Services, the incidence rates of cardiovascular outcomes were calculated for individuals aged ≥ 25 (~2.7 million adults per year) during the first (Y1, 3/2020–2/2021) and second (Y2, 3/2021–2/2022) years of COVID-19 and the 8 years prior (3/2012–2/2020). Declines were observed in Y1 compared to 2019 in all diagnoses and treatments: STEMI (−16.3%; 95% CI: −16.6, −16.1), non-STEMI (−16.4%; −16.6, −16.2), AF (−14.1%; −14.2, −14.0), CHF (−7.8%; −7.9, −7.7), CVA (−5.0%; −5.0, −4.9), catheterization (−64.7%; −65.2, −64.2), CABG (−77.7%; −79.2, −76.2), ablation (−21.2%; −22.0, −20.4), pacemaker implantation (−39.3%; −40.7, −37.9), and defibrillator insertion (−12.5%; −13.1, −12.0). Compared with expected rates based on pre-pandemic trends, observed rates were within expected ranges (CHF, CVA, and ablation), less than expected (STEMI, non-STEMI, AF, catheterization, CABG, and pacemaker insertion), or more than expected (defibrillator insertion). In Y2, STEMI, catheterization, and CABG returned to expected rates; non-STEMI and AF were lower than expected; and CHF, CVA, ablation, and pacemaker and defibrillator implantations were higher than expected. Several cardiovascular diagnoses and treatment trends were interrupted by COVID-19. The long-term consequences of these changes should be considered by health policymakers.

20 February 2026 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
YAYuval Avidan
Yuval Avidan
RKRazi Khoury
Razi Khoury
HSHani Sliman
Hani Sliman
SZSameha Zahra
Sameha Zahra
ADAsaf Danon
Asaf Danon
SKSameer Kassem
Sameer Kassem